Elon Musk’s artificial intelligence software, Grok, continues to generate sexualized images of people without their consent, despite his company’s pledge months ago to halt abusive deepfakes after a ...

Samir Kapadia, Managing Principal at Vogel Group, says the first issue that needs to be addressed on the Strait of Hormuz is whether Iran can make revenue from it, as it wants a 'sanctions shield' to ...

New research has discovered that the molecular machines responsible for copying our DNA have a surprising hidden talent: an ability to create entirely new and highly sophisticated DNA sequences from ...

U.S. President Donald Trump on Monday warned Iran to immediately reopen the strategically vital Strait of Hormuz or risk attacks on its oil wells and power plants. His comments come as the sprawling ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

In January, OpenAI’s handpicked council of advisers on well-being and AI met with the company’s representatives for an update about a controversial new feature called “adult mode.” Citing the need to ...

With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its chatbot better at explaining some concepts. Starting today, Claude can ...

BOXX replicates Treasury bill returns using options. The ETF uses a box spread strategy built from SPY call and put options to create a defined payout that closely tracks the risk-free rate. The ...

There's a new, two-story structure at the BNP Paribas Open this year, and it's drawing quite a bit of attention. You can’t miss this new place to sit and relax when you walk through the Indian Wells ...

Generate:Biomedicines has hit the public markets as the world begins to question the usefulness of AI technology. CEO Mike Nally says biology is the key to unlocking the technology’s full potential.

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...